Nano-X CEO buys 10,000 shares at $0.78

Nano-X Imaging’s CEO made an open-market share purchase and continues to hold sizeable vested and unvested stock options.

Rhea-AI Filing Summary

Nano-X Imaging Ltd. (NNOX) reported that Chief Executive Officer and director Erez Meltzer, through his wholly owned company Oud Nof, purchased 10,000 ordinary shares on September 10, 2026 at $0.78 per share, increasing his indirect holdings to 55,443 shares. He also holds 60,584 ordinary shares directly and stock options over 40,234 shares at $2.21 (expiring February 11, 2030), 300,000 shares at $23.84 (expiring January 2, 2032), and 150,000 shares at $11.52 (expiring April 16, 2034). The 2024 option grant vests 25% after one year and 6.25% quarterly over the following three years, becoming fully vested on April 16, 2028. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Buyer: 10,000 shares

Net Buy 5 txns

Insider Meltzer Erez

Role Chief Executive Officer

Bought 10,000 shs ($8K)

Type	Security	Shares	Price	Value
Purchase	Ordinary Shares F1	10,000	$0.78	$8K
holding	Stock Option (right to buy ordinary shares) F2, F3	--	--	--
holding	Stock Option (right to buy ordinary shares) F2, F4	--	--	--
holding	Stock Option (right to buy ordinary shares) F2, F5	--	--	--
holding	Ordinary Shares F2	--	--	--

Holdings After Transaction: Ordinary Shares — 55,443 shares (Indirect, By a wholly owned company); Stock Option (right to buy ordinary shares) — 490,234 contracts (Direct); Ordinary Shares — 60,584 shares (Direct)

Footnotes (5)

1. F1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
2. F2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
3. F3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
4. F4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
5. F5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).

Key Figures

Shares purchased: 10,000 ordinary shares Purchase price: $0.78 per share Indirect holdings after transaction: 55,443 ordinary shares +4 more

7 metrics

Shares purchased 10,000 ordinary shares Open-market purchase on September 10, 2026

Purchase price $0.78 per share Price paid for 10,000 ordinary shares on September 10, 2026

Indirect holdings after transaction 55,443 ordinary shares Indirectly held through wholly owned company Oud Nof

Direct ordinary share holdings 60,584 ordinary shares Direct holdings reported as of this Form 4

Stock options at $2.21 40,234 underlying shares Exercise price $2.21, expiring February 11, 2030; fully vested

Stock options at $23.84 300,000 underlying shares Exercise price $23.84, expiring January 2, 2032; fully vested

Stock options at $11.52 150,000 underlying shares Exercise price $11.52, expiring April 16, 2034; vesting through April 16, 2028

Key Terms

indirect ownership, Stock Option (right to buy ordinary shares), fully vested and exercisable, vest and become exercisable, +1 more

5 terms

indirect ownership financial

"Indirect holdings are reported as "By a wholly owned company""

Stock Option (right to buy ordinary shares) financial

"Stock Option (right to buy ordinary shares) with specified exercise price"

fully vested and exercisable financial

"options reported in this row were granted ... and are fully vested and exercisable"

vest and become exercisable financial

"options ... vest and become exercisable in accordance with the following schedule"

wholly owned company financial

"shares were purchased by Oud Nof, a company wholly owned by the Reporting Person"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did NNOX CEO Erez Meltzer do in this Form 4 filing?

He purchased 10,000 Nano-X Imaging (NNOX) ordinary shares on September 10, 2026 at $0.78 per share through his wholly owned company Oud Nof, increasing his indirectly held position in the company.

How many NNOX shares does the CEO hold after this transaction?

After the transaction, Erez Meltzer holds 55,443 ordinary shares indirectly through Oud Nof and 60,584 ordinary shares directly, according to the holdings reported in the Form 4 filing.

Was the NNOX CEO’s share purchase under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, so no Rule 10b5-1 trading plan is reported for the September 10, 2026 purchase.

What stock options on NNOX shares does the CEO currently hold?

He holds options over 40,234 shares at $2.21 expiring February 11, 2030; 300,000 shares at $23.84 expiring January 2, 2032; and 150,000 shares at $11.52 expiring April 16, 2034, all referencing Nano-X ordinary shares.

Are the NNOX stock options held by the CEO vested?

Options granted on February 11, 2020 and January 2, 2020 are fully vested and exercisable. Options granted on April 16, 2024 vest 25% after one year and 6.25% quarterly, becoming fully vested on April 16, 2028.

How is the NNOX CEO’s indirect ownership structured?

The 10,000 shares purchased, and the 55,443 ordinary shares reported as indirectly held, are owned through Oud Nof, which the footnotes describe as a company wholly owned by the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 08:00 AM Accepted by SEC EDGAR 09/14/2026 - 07:59 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meltzer Erez

(Last) (First) (Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares(1)	09/10/2026		P		10,000	A	$0.78	55,443	I	By a wholly owned company(1)
Ordinary Shares(2)								60,584	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)(2)	$2.21							(3)	02/11/2030	Ordinary Shares	40,234		40,234	D
Stock Option (right to buy ordinary shares)(2)	$23.84							(4)	01/02/2032	Ordinary Shares	300,000		300,000	D
Stock Option (right to buy ordinary shares)(2)	$11.52							(5)	04/16/2034	Ordinary Shares	150,000		150,000	D

Explanation of Responses:

1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.

2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.

4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.

5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).

Remarks:

See Exhibit 24.1: Power of Attorney

	/s/ Marina Gofman Feler, attorney-in-fact	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)